MTNR1A encodes a high-affinity melatonin receptor that mediates circadian rhythm regulation and reproductive functions 1. As a G-protein-coupled receptor, MTNR1A signals through pertussis toxin-sensitive G proteins to inhibit adenylate cyclase activity, modulating synaptic transmission and potentially inducing sleep 2. The receptor is expressed in pancreatic beta cells where it regulates glucose homeostasis and insulin secretion 3. MTNR1A variants are associated with multiple metabolic and skeletal disorders. Genome-wide association studies identified three novel MTNR1A variants linked to type 2 diabetes in Italian families 3, while separate studies found MTNR1A polymorphisms associated with altered lipid profiles and vascular stiffness parameters in healthy individuals 4. Most significantly, rare loss-of-function MTNR1A variants (rs374152717 and rs28383653) cause idiopathic osteoporosis through osteoblast senescence and impaired bone turnover, with elevated prevalence in Ashkenazi Jewish populations 5. In contrast, MTNR1A promoter polymorphisms showed no association with adolescent idiopathic scoliosis 6. MTNR1A is also expressed in salivary gland ducts and Warthin's tumors, suggesting roles in salivary regulation and tumor pathology 7. These findings establish MTNR1A as a multifunctional receptor with implications for metabolic, skeletal, and endocrine diseases.